JPWO2021241428A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021241428A5
JPWO2021241428A5 JP2022526975A JP2022526975A JPWO2021241428A5 JP WO2021241428 A5 JPWO2021241428 A5 JP WO2021241428A5 JP 2022526975 A JP2022526975 A JP 2022526975A JP 2022526975 A JP2022526975 A JP 2022526975A JP WO2021241428 A5 JPWO2021241428 A5 JP WO2021241428A5
Authority
JP
Japan
Prior art keywords
sialidase
elastin
elastin production
production promoter
promoter according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022526975A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021241428A1 (cg-RX-API-DMAC7.html
JP7312993B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/019322 external-priority patent/WO2021241428A1/ja
Publication of JPWO2021241428A1 publication Critical patent/JPWO2021241428A1/ja
Publication of JPWO2021241428A5 publication Critical patent/JPWO2021241428A5/ja
Application granted granted Critical
Publication of JP7312993B2 publication Critical patent/JP7312993B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022526975A 2020-05-25 2021-05-21 エラスチン産生促進剤及び皮膚化粧料 Active JP7312993B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020090313 2020-05-25
JP2020090313 2020-05-25
PCT/JP2021/019322 WO2021241428A1 (ja) 2020-05-25 2021-05-21 エラスチン産生促進剤及び皮膚化粧料

Publications (3)

Publication Number Publication Date
JPWO2021241428A1 JPWO2021241428A1 (cg-RX-API-DMAC7.html) 2021-12-02
JPWO2021241428A5 true JPWO2021241428A5 (cg-RX-API-DMAC7.html) 2023-02-02
JP7312993B2 JP7312993B2 (ja) 2023-07-24

Family

ID=78744733

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022526975A Active JP7312993B2 (ja) 2020-05-25 2021-05-21 エラスチン産生促進剤及び皮膚化粧料

Country Status (5)

Country Link
US (1) US20230233437A1 (cg-RX-API-DMAC7.html)
EP (1) EP4159284A4 (cg-RX-API-DMAC7.html)
JP (1) JP7312993B2 (cg-RX-API-DMAC7.html)
CN (1) CN115515558B (cg-RX-API-DMAC7.html)
WO (1) WO2021241428A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116059309B (zh) * 2023-04-06 2023-06-30 江西中医药大学 一种精油组合物及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07114695B2 (ja) * 1986-06-16 1995-12-13 丸金醤油株式会社 ノイラミニダ−ゼの製造法
JP2557240B2 (ja) * 1987-12-21 1996-11-27 雪印乳業株式会社 皮膚老化予防剤
GB9207280D0 (en) * 1992-04-02 1992-05-13 Unilever Plc Skin care method and composition
DE19649096A1 (de) * 1996-11-27 1998-05-28 Beiersdorf Ag Antiadhäsive Glycosidasen
EP1356823B1 (en) * 1998-02-25 2013-01-02 THE GOVERNMENT OF THE UNITED STATES, as represented by THE SECRETARY OF THE ARMY Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response induced by an adjuvant
FR2816504B1 (fr) * 2000-11-13 2003-04-18 Oreal Compositions comprenant au moins une glycosidase, lesdites compositions ne comprenant pas de protease
EP1349567A4 (en) * 2000-12-08 2005-10-12 Childrens Memorial Hospital COMPOSITIONS WITH GANGLIOSIDES FOR USE IN THE TREATMENT OF SKIN DISEASES
WO2003052104A1 (en) * 2001-12-14 2003-06-26 Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin A reporter gene
US20060270707A1 (en) * 2005-05-24 2006-11-30 Zeldis Jerome B Methods and compositions using 4-[(cyclopropanecarbonylamino)methyl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione for the treatment or prevention of cutaneous lupus
JP6240447B2 (ja) 2012-12-26 2017-11-29 新田ゼラチン株式会社 エラスチン産生促進剤
JP6259207B2 (ja) 2013-06-17 2018-01-10 雪印メグミルク株式会社 エラスチン産生促進剤
SG10202100652VA (en) * 2015-07-21 2021-03-30 Univ Jefferson Gene therapies for neurodegenerative disorders targeting ganglioside biosynthetic pathways
CN105617402A (zh) * 2016-01-15 2016-06-01 江南大学 一种唾液酸酶Neu1在制备药物方面的用途
JP6990903B2 (ja) 2016-06-09 2022-02-15 静岡県公立大学法人 シアリダーゼ阻害活性を有する化合物を含むインスリン分泌促進剤、血糖値上昇抑制剤及び糖尿病治療剤、並びにそれらの剤のスクリーニング方法

Similar Documents

Publication Publication Date Title
JP2021513520A5 (cg-RX-API-DMAC7.html)
BR0315716A (pt) Composição e método para o tratamento dos cabelos
MXPA01006917A (es) Composicion topica que comprende n-acetilaldosaminas o acidos n-acetilaminos.
PT1227820E (pt) Acidos oligossacarido-aldonicos e sua utilizacao topica
ATE515253T1 (de) Zusammensetzungen auf basis von etyllinoleat und triethylcitrat zur behandlung von seborrhöe und akne
RU2011103256A (ru) Крем-пена для ухода за кожей
EP2983678B1 (en) Anti-microbial composition
EP2146688A4 (en) COSMETIC COMPOSITION FOR LIGHTING UP THE SKIN WITH MAGNOLIA SIEBOLDII EXTRACT AS AN ACTIVE SUBSTANCE
BR0210374A (pt) Amidas de ácido antranìlico com cadeia lateral de heteroarilsulfonila, processos para produção das mesmas, uso das mesmas como medicamento ou agente de diagnóstico, bem como preparações farmacêuticas que contêm as mesmas
CA2627454A1 (en) Hyaluronidase inhibitor containing poly-gamma-glutamic acid as an effective component
JP2021001133A5 (cg-RX-API-DMAC7.html)
EP2051690A2 (en) Use of c-glycoside derivatives as pro-desquamating active agents
WO2023143335A9 (zh) 一种诱导皮肤组织再生的亲水性静电纺植入物
ATE553760T1 (de) Verwendung von alverin zur behandlung von hauterkrankungen
WO2004033660A3 (en) Gene expression profiling from ffpe samples
MX2024010931A (es) Biosurfactantes espumantes mejorados.
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
JP2007023038A (ja) 落屑を促進するための尿素化合物の使用
Sandhu et al. Potassium iodide remains the most effective therapy for cutaneous sporotrichosis
DE602006008186D1 (de) Neues imprägnierverfahren einer textiloberfläche
BR0308040A (pt) Composições farmacêuticas e cosméticas compreendendo plgf-1
JP1774466S (ja) 抗しわ器具
ATE318131T1 (de) Kosmetische zubereitung gegen hautfalten
FI4138881T3 (fi) Koostumus, joka käsittää dnaasi i:n käytettäväksi menetelmässä, jolla estetään aim2-inflammasomin aktivaatio
RU2016103388A (ru) Косметическая композиция, содержащая трехкомпонентную липидную ассоциацию для контроля сухости кожи